Pioneer Group

ImmuONE is a biotech company focused on providing in vitro cell culture services for safety assessment, particularly in the realm of inhalation toxicology. The company specializes in human alveolar macrophage responses and epithelial cell culture platforms, offering testing services that aim to enhance understanding of respiratory health. Additionally, ImmuONE develops respiratory tissue models that closely mimic lung physiology, ensuring that their results are relevant, reliable, and reproducible. Through these advanced techniques, ImmuONE supports healthcare providers in the development of innovative products and testing services for inhalation safety assessment.

Neobe Therapeutics provides immunotherapies, clinical trials, research, and tumor-colonizing bacteria engineering services.

ImmuONE is a biotech company focused on providing in vitro cell culture services for safety assessment, particularly in the realm of inhalation toxicology. The company specializes in human alveolar macrophage responses and epithelial cell culture platforms, offering testing services that aim to enhance understanding of respiratory health. Additionally, ImmuONE develops respiratory tissue models that closely mimic lung physiology, ensuring that their results are relevant, reliable, and reproducible. Through these advanced techniques, ImmuONE supports healthcare providers in the development of innovative products and testing services for inhalation safety assessment.

Bastion Therapeutics is a preclinical stage biotechnology startup focused on developing innovative anti-inflammatory cell therapies. The company utilizes proprietary platform technology to enhance regulatory T cells (Tregs) within the immune system. By targeting neuroinflammation in the central nervous system, Bastion's therapies aim to protect neurons and improve synaptic connectivity. This approach seeks to help patients maintain cognitive function and prevent its decline, addressing significant challenges in neurodegenerative conditions.

NunaBio is a privately-owned DNA development company based in England, United Kingdom. The company specializes in creating a variety of chemical and biological technologies and products, including long and short deoxyribonucleic acid (DNA) products available in microgram to gram scales. NunaBio is involved in contract research and development, as well as manufacturing services, offering expertise in cell therapies, vaccines, diagnostics, and gene therapies. Additionally, the company focuses on advanced DNA biosensing and associated consumables, supporting healthcare professionals in their efforts to treat patients effectively.

Transdermal Diagnostics is a technology company focused on enhancing the prevention, diagnosis, and management of chronic conditions, particularly diabetes. The firm has developed a wearable technology platform that facilitates needle-free and continuous monitoring of blood sugar levels. This is achieved through the use of affordable disposable patches, which provide users with valuable biological insights. By enabling individuals with diabetes and prediabetes to monitor their condition more effectively, Transdermal Diagnostics aims to empower users to make informed decisions that contribute to healthier lifestyles.